Skip to main content

Advertisement

Log in

Cancer Bio-Immunotherapy in Siena”: Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17–19, 2013

  • Meeting Report
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abbreviations

CAR:

Chimeric antigen receptor

CIK:

Cytokine-induced killer

CRC:

Colorectal cancer

CSCs:

Cancer stem cells

CTA:

Cancer testis antigens

DCs:

Dendritic cells

IFN:

Interferon

mAbs:

Monoclonal antibodies

NK:

Natural killer

TREM:

Triggering receptor expressed on myeloid cells

Acknowledgments

This meeting report was supported in part by grants from Associazione Italiana per la Ricerca sul Cancro and Istituto Toscano Tumori. A special thanks to the NIBIT members and meeting speakers for their contribution to the manuscript and the conference.

Conflict of interest

The authors declare that they have no conflict of interest. Michele Maio, Ester Fonsatti and Giorgio Parmiani: Local Organizing Committee Michele Maio and Giorgio Parmiani: Scientific Organizing Committee.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michele Maio.

Additional information

This meeting report is a summary of presentations from the Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, published together with a series of Focussed Research Reviews based on lectures given at the conference.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maio, M., Nicolay, H.J.M., Cutaia, O. et al.Cancer Bio-Immunotherapy in Siena”: Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17–19, 2013. Cancer Immunol Immunother 64, 131–135 (2015). https://doi.org/10.1007/s00262-014-1577-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-014-1577-0

Keywords

Navigation